Stay updated on Elsubrutinib & Upadacitinib in SLE Clinical Trial

Sign up to get notified when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elsubrutinib & Upadacitinib in SLE Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. The old revision tag was removed along with the 'Back to Top' element.
    Difference
    0.5%
    Check dated 2025-09-13T17:36:11.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.5%
    Check dated 2025-09-06T15:13:37.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, while also removing specific location details such as state, country, and city information.
    Difference
    51%
    Check dated 2025-08-30T11:55:37.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:51:19.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11.
    Difference
    0.3%
    Check dated 2025-08-09T00:19:55.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-01T19:34:55.000Z thumbnail image

Stay in the know with updates to Elsubrutinib & Upadacitinib in SLE Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.